玖玖资源网站,爆乳久久久,日韩精品乱码久久久蜜桃,精品呦国产一区二区三区,国产伦高清一区二区三区,sese一区二区,午夜精品福利一区二区三区,三级黄色网站久久免费

首頁
訂購/客服:400-666-5481

Ponesimod ( ACT-128800)

    
99.2%

(2Z,5Z)-5-(3-chloro-4-((R)-2,3-dihydroxypropoxy)benzylidene)-2-(propyliMino)-3-(o-tolyl)thiazolidin-4-one

源葉(MedMol)
S81011 一鍵復制產品信息
854107-55-4
C23H25ClN2O4S
460.9736
4-Thiazolidinone, 5-[[3-chloro-4-[(2R)-2,3-dihydroxypropoxy]phenyl]Methylene]-3-(2-Methylphen
貨號 規格 價格 上海 北京 武漢 南京 購買數量
S81011-5mg
99.2% ¥500.00 9 - - -
S81011-10mg
99.2% ¥900.00 8 - - -
S81011-25mg
99.2% ¥1600.00 7 - - -
S81011-100mg
99.2% ¥4100.00 7 - - -
產品介紹 參考文獻 質檢證書(COA) 摩爾濃度計算器 相關產品

產品介紹

Ponesimod (ACT-128800) is a potent, selective and orally active agonist of S1P1, with an IC50 of 6 nM in a radioligand binding assay. Ponesimod activates S1P1-mediated signal transduction with high potency (EC50=5.7 nM). Ponesimod can protect against lymphocyte-mediated tissue inflammation

產品描述: Ponesimod (ACT-128800) is a potent, selective and orally active agonist of S1P1, with an IC50 of 6 nM in a radioligand binding assay. Ponesimod activates S1P1-mediated signal transduction with high potency (EC50=5.7 nM). Ponesimod can protect against lymphocyte-mediated tissue inflammation
靶點: S1PR1:6 nM (IC50);S1PR3:2068 nM (IC50);S1PR4:1956 nM (IC50);S1PR5:142 nM (IC50);S1PReceptor;?LPLReceptor
體內研究: Ponesimod (30 and 175 mg/kg; once daily p.o. for 8 d) prevents delayed-type hypersensitivity in mice. Ponesimod (30 mg/kg by gavage 3 h before and 6 h after adjuvant injection followed by 100 mg/kg/day by administration as food admix for 18 days) prevents adjuvant-induced arthritis in rats. Ponesimod (0.3-100 mg/kg; a single oral gavage) causes a dose-dependent reduction in lymphocyte count, with a plateau effect being reached at 3 mg/kg in rats. Ponesimod (100 mg/kg; once daily oral gavage for 7 d) results in a lymphocyte count reduction to 1900 lymphocytes/μL, and this effect is maintained over the entire 7 days studies. Lymphocyte count returned to baseline levels within 48 h after discontinuation of dosing.
參考文獻: 1. Bolli MH, et al. 2-imino-thiazolidin-4-one derivatives as potent, orally active S1P1 receptor agonists. J Med Chem. 2010 May 27;53(10):4198-211. 2. Piali L, et al. The selective sphingosine 1-phosphate receptor 1 agonist ponesimod protects against lymphocyte-mediated tissue inflammation. J Pharmacol Exp Ther. 2011 May;337(2):547-56. 3. Brossard P, et al. Pharmacokinetics and pharmacodynamics of ponesimod, a selective S1P1 receptor modulator, in the first-in-human study. Br J Clin Pharmacol. 2013 Dec;76(6):888-96.
溶解性: DMSO  :  ≥  100  mg/mL  (216.93  mM)
保存條件: 2-8℃
配置溶液濃度參考:
1mg 5mg 10mg
1 mM 2.169 ml 10.847 ml 21.693 ml
5 mM 0.434 ml 2.169 ml 4.339 ml
10 mM 0.217 ml 1.085 ml 2.169 ml
50 mM 0.043 ml 0.217 ml 0.434 ml
注意: 部分產品我司僅能提供部分信息,我司不保證所提供信息的權威性,僅供客戶參考交流研究之用。

參考文獻

質檢證書(COA)

如何獲取質檢證書(COA)?
請輸入貨號和一個與之匹配的批號。
例如:
批號:JS298415 貨號:S20001-25g
在貨品標簽上如何找到貨號和批號?

摩爾濃度計算器

質量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)

=
×
×
主站蜘蛛池模板: 鲜城| 彭山县| 贺州市| 淮滨县| 丹凤县| 焦作市| 常山县| 苏州市| 禹城市| 桂平市| 宁夏| 莫力| 麦盖提县| 西华县| 大英县| 承德市| 松滋市| 武鸣县| 永州市| 旌德县| 武威市| 临清市| 萨嘎县| 平阴县| 邢台市| 安岳县| 缙云县| 泸州市| 连山| 陇南市| 大方县| 子长县| 慈溪市| 东平县| 凤庆县| 内乡县| 白河县| 黄骅市| 抚松县| 水富县| 临汾市|